Literature DB >> 15073534

Gigaxonin is associated with the Golgi and dimerises via its BTB domain.

Valerie C Cullen1, Janet Brownlees, Steven Banner, Brian H Anderton, P Nigel Leigh, Christopher E Shaw, Christopher C J Miller.   

Abstract

Mutations in the gigaxonin gene cause giant axonal neuropathy. The amino-terminus of gigaxonin contains a BTB domain but no binding partners for this domain have so far been identified. Here, we demonstrate that the gigaxonin BTB domain forms homodimers. Other BTB-bearing proteins have also been shown to dimerise via their BTB domains with the dimers then capable of interacting with other ligands. Thus, the gigaxonin BTB domain may function in a similar manner. We also demonstrate that gigaxonin is expressed in a wide variety of neuronal cell types where a significant proportion exists in cell bodies. Confocal microscope studies of gigaxonin-transfected COS-7 cells and cultured neurones revealed that a proportion of gigaxonin localises to the Golgi and endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073534     DOI: 10.1097/00001756-200404090-00028

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  KRIP6: a novel BTB/kelch protein regulating function of kainate receptors.

Authors:  Fernanda Laezza; Timothy J Wilding; Sunitha Sequeira; Françoise Coussen; Xue Zhao Zhang; Rona Hill-Robinson; Christophe Mulle; James E Huettner; Ann Marie Craig
Journal:  Mol Cell Neurosci       Date:  2007-01-24       Impact factor: 4.314

Review 2.  A CULLINary ride across the secretory pathway: more than just secretion.

Authors:  Albert Lu; Suzanne R Pfeffer
Journal:  Trends Cell Biol       Date:  2014-03-11       Impact factor: 20.808

3.  A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice.

Authors:  Yan Jiao; Xiudong Jin; Jian Yan; Chi Zhang; Feng Jiao; Xinmin Li; Bruce A Roe; David B Mount; Weikuan Gu
Journal:  Genomics       Date:  2008-03-14       Impact factor: 5.736

Review 4.  A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.

Authors:  James J Kang; Isabelle Y Liu; Marilene B Wang; Eri S Srivatsan
Journal:  Hum Genet       Date:  2016-03-29       Impact factor: 4.132

5.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

6.  Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.

Authors:  Bethany L Johnson-Kerner; Alejandro Garcia Diaz; Sean Ekins; Hynek Wichterle
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

7.  Novel homozygous missense mutation in GAN associated with Charcot-Marie-Tooth disease type 2 in a large consanguineous family from Israel.

Authors:  Sharon Aharoni; Katy E S Barwick; Rachel Straussberg; Gaurav V Harlalka; Yoram Nevo; Barry A Chioza; Meriel M McEntagart; Aviva Mimouni-Bloch; Michael Weedon; Andrew H Crosby
Journal:  BMC Med Genet       Date:  2016-11-16       Impact factor: 2.103

Review 8.  E3 Ubiquitin Ligases in Neurological Diseases: Focus on Gigaxonin and Autophagy.

Authors:  Léa Lescouzères; Pascale Bomont
Journal:  Front Physiol       Date:  2020-10-22       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.